Empa and ETH Zurich researchers usually work on measuring, analyzing, and reducing airborne pollutants, however, their new focus: a sensor that can quickly detect SARS-CoV-2.
Jing Wang and his team at Empa and ETH Zurich usually work on measuring, analyzing, and reducing airborne pollutants such as aerosols and artificially produced nanoparticles. However, the challenge the whole world is currently facing is changing the goals and strategies in the research laboratories. The new focus: a sensor that can quickly and reliably detect SARS-CoV-2 - the new coronavirus, according to a news release.
But the idea is not quite so far removed from the group's previous research work. Even before COVID-19 began to spread first in China and then around the world, Wang and his colleagues were researching sensors that could detect bacteria and viruses in the air. As early as January, the idea of using this basis to further develop the sensor in such a way that it could reliably identify a specific virus was born. The sensor will not necessarily replace the established laboratory tests, but could be used as an alternative method for clinical diagnosis, and more prominently to measure the virus concentration in the air in real time. For example, in busy places like train stations or hospitals.
Fast and reliable tests for the new coronavirus are urgently needed to bring the pandemic under control as soon as possible. Most laboratories use a molecular method called reverse transcription polymerase chain reaction, or RT-PCR, to detect viruses in respiratory infections. This is well established and can detect even tiny amount of viruses - but at the same time it can be time consuming and prone to error.
An optical sensor for RNA samples
Wang and his team have developed an alternative test method in the form of an optical biosensor. The sensor combines two different effects to detect the virus safely and reliably: an optical and a thermal one.
Related: The Taiwan Example: Community Pharmacists Helped Keep COVID-19 Deaths, Cases Way Down
The sensor is based on tiny structures of gold, so-called gold nanoislands, on a glass substrate. Artificially produced DNA receptors that match specific RNA sequences of the SARS-CoV-2 are grafted onto the nanoislands. The coronavirus is a so-called RNA virus and its genome does not consist of a DNA double strand as in living organisms, but of a single RNA strand. The receptors on the sensor are therefore the complementary sequences to the virus' unique RNA sequences, which can reliably identify the virus.
The technology the researchers use for detection is called localized surface plasmon resonance, or LSPR. This is an optical phenomenon that occurs in metallic nanostructures. When excited, they modulate the incident light in a specific wavelength range and create a plasmonic near-field around the nanostructure. When molecules bind to the surface, the local refractive index within the excited plasmonic near-field changes. An optical sensor located on the back of the sensor can be used to measure this change and thus determine whether the sample contains the RNA strands in question.
Heat increases reliability
However, it is important that only those RNA strands match exactly to the DNA receptor on the sensor that are captured. This is where a second effect comes into play on the sensor: the plasmonic photothermal (PPT) effect. If the same nanostructure on the sensor is excited with a laser of a certain wavelength, it produces localized heat.
How does that help reliability? The genome of the virus consists of only a single strand of RNA. If this strand finds its complementary counterpart, the two combine to form a double strand - a process called hybridization. The counterpart - when a double strand splits into single strands - is called melting or denaturation. This happens at the melting temperature. However, if the ambient temperature is much lower than the melting temperature, strands that are not complementary to each other can also connect. This could lead to false test results. If the ambient temperature is only slightly lower than the melting temperature, only complementary strands can join. And this is exactly the result of the increased ambient temperature, which is caused by the PPT effect.
To demonstrate how reliably the new sensor detects the current COVID-19 virus, the researchers tested it with a very closely related virus: SARS-CoV. This is the virus that broke out in 2003 and triggered the SARS pandemic. The two viruses: SARS-CoV and SARS-CoV2 differ only slightly in their RNA.
And validation was successful: "Tests showed that the sensor can clearly distinguish between the very similar RNA sequences of the two viruses," explains Wang. And the results are ready in a matter of minutes.
At the moment, however, the sensor is not yet ready to measure the coronavirus concentration in the air, for example, in Zurich's main railway station. A number of developmental steps are still needed to do this, such as a system that draws in the air, concentrates the aerosols in it, and releases the RNA from the viruses.
"This still needs development work," says Wang. But once the sensor is ready, the principle could be applied to other viruses and help to detect and stop epidemics at an early stage.
This week on Tuning Into The C-Suite Briana Contreras spoke with Dr. Scott Hayworth, president and CEO of New York-based CareMount Medical. In this interview, the two discussed the importance of patients staying in contact with their doctors for the sake of reducing public health risks and to discuss ongoing care options with them.
Listen
Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients
July 22nd 2020MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.
Listen